Key publications

2016
1. Pancreatic Pre-malignant Lesions Secrete TIMP1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Pre-Metastatic Niche in the Liver.
Grünwald B, Harant V, Schaten S, Frühschütz M, Spallek R, Höchst B, Stutzer K, Berchtold S, Erkan M, Prokopchuk O, Martignoni M, Esposito I, Heikenwalder M, Gupta A, Siveke J, Saftig P, Knolle P, Wohlleber D, Krüger A
Gastroenterology. 2016 Aug 6.
PMID: 27506299 [PubMed - as supplied by publisher]
2015
2. Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.
Seubert B, Grünwald B, Kobuch J, Cui H, Schelter F, Schaten S, Siveke JT, Lim NH, Nagase H, Simonavicius N, Heikenwalder M, Reinheckel T, Sleeman JP, Janssen KP, Knolle PA, Krüger A
Hepatology. 2015 Jan .
PMID: 25131778 [PubMed - in process]
2013
3. Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion.
Höchst B, Schildberg FA, Sauerborn P, Gäbel YA, Gevensleben H, Goltz D, Heukamp LC, Türler A, Ballmaier M, Gieseke F, Müller I, Kalff J, Kurts C, Knolle PA, Diehl L
J Hepatol. 2013 Sep .
PMID: 23665041 [PubMed - in process]
4. Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection.
Huang LR, Wohlleber D, Reisinger F, Jenne CN, Cheng RL, Abdullah Z, Schildberg FA, Odenthal M, Dienes HP, van Rooijen N, Schmitt E, Garbi N, Croft M, Kurts C, Kubes P, Protzer U, Heikenwalder M, Knolle PA
Nat Immunol. 2013 Jun .
PMID: 23584070 [PubMed - in process]
5. Liver-primed memory T cells generated under noninflammatory conditions provide anti-infectious immunity.
Böttcher JP, Schanz O, Wohlleber D, Abdullah Z, Debey-Pascher S, Staratschek-Jox A, Höchst B, Hegenbarth S, Grell J, Limmer A, Atreya I, Neurath MF, Busch DH, Schmitt E, van Endert P, Kolanus W, Kurts C, Schultze JL, Diehl L, Knolle PA
Cell Rep. 2013 Mar 28.
PMID: 23499443 [PubMed - in process]
2012
6. TNF-induced target cell killing by CTL activated through cross-presentation.
Wohlleber D, Kashkar H, Gärtner K, Frings MK, Odenthal M, Hegenbarth S, Börner C, Arnold B, Hämmerling G, Nieswandt B, van Rooijen N, Limmer A, Cederbrant K, Heikenwalder M, Pasparakis M, Protzer U, Dienes HP, Kurts C, Krönke M, Knolle PA
Cell Rep. 2012 Sep 27.
PMID: 22939982 [PubMed - in process]
7. Optimizing adenoviral transduction of endothelial cells under flow conditions.
Anton M, Wolf A, Mykhaylyk O, Koch C, Gansbacher B, Plank C
Pharm Res. 2012 May .
PMID: 22207207 [PubMed - in process]
8. Transfer of HBV genomes using low doses of adenovirus vectors leads to persistent infection in immune competent mice.
Huang LR, Gäbel YA, Graf S, Arzberger S, Kurts C, Heikenwalder M, Knolle PA, Protzer U
Gastroenterology. 2012 Jun .
PMID: 22426294 [PubMed - in process]
2011
9. Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells.
Hoechst B, Gamrekelashvili J, Manns MP, Greten TF, Korangy F
Blood. 2011 Jun 16.
PMID: 21493801 [PubMed - in process]
10. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells.
Sanchez-Antequera Y, Mykhaylyk O, van Til NP, Cengizeroglu A, de Jong JH, Huston MW, Anton M, Johnston IC, Pojda Z, Wagemaker G, Plank C
Blood. 2011 Apr 21.
PMID: 21357765 [PubMed - in process]
Page 12